BLIN Stock Climbs Before Holiday Break as Bridgeline’s AI Sales Push Faces Revenue Test

May 22, 2026
BLIN Stock Climbs Before Holiday Break as Bridgeline’s AI Sales Push Faces Revenue Test

NEW YORK, May 22, 2026, 17:03 EDT

Bridgeline Digital Inc. shares closed regular Nasdaq trading higher on Friday, finishing at $0.94, up 2.24%, after swinging between $0.87 and $0.95. Volume was light at about 26,200 shares, and the company’s market value stood near $11.8 million.

That makes BLIN a microcap, meaning a company with a very small public market value, and one where modest order flow can move the stock. The timing also matters: Nasdaq lists Monday, May 25, as a full market closure for Memorial Day, leaving investors with a long weekend to digest the company’s latest numbers.

The latest filing showed the basic tension. Revenue for the quarter ended March 31 rose only slightly, to $3.917 million from $3.875 million a year earlier, while the net loss narrowed to $432,000 from $730,000. Cash and cash equivalents were $1.373 million at quarter-end.

The sales pipeline looked better than the income statement. Bridgeline said it sold 19 new subscription contracts in the quarter, worth $2.8 million in total contract value, and added $875,000 in annual recurring revenue, or ARR — the yearly sales base expected from subscription contracts.

Chief Executive Ari Kahn pushed that point on the earnings call, saying Bridgeline had “tripled last quarter’s sales” and delivered the most new-logo sales in the company’s history. He tied the gains to larger customers and add-ons for HawkSearch, the company’s product-search and merchandising software. Investing

But the downside case is still plain. Bridgeline’s own 10-K says its markets are “highly competitive, fragmented, and rapidly changing,” and names Algolia, Bloomreach and Coveo among rivals; larger competitors and lower-priced products could pressure sales or margins if new AI bookings do not turn into recognized revenue fast enough. SEC

The broader tape was no drag. U.S. stocks rose Friday, with the Dow closing at a record and the S&P 500 and Nasdaq also higher, as investors leaned into earnings strength and hopes around Middle East talks ahead of the holiday weekend.

There was no new company event on Bridgeline’s newsroom calendar, which listed no upcoming events. That leaves next week’s trade less about a scheduled catalyst and more about whether investors keep giving the company credit for AI bookings before revenue growth clearly follows.

Stock Market Today

  • Pro Medicus (PME) Share Price and Healthcare Sector Appeal on ASX
    May 22, 2026, 6:56 PM EDT. The Pro Medicus Ltd (ASX:PME) share price has dropped 42.5% since early 2025, prompting investor interest in healthcare stocks. Pro Medicus offers radiology IT software, including its flagship Visage platform that enables remote access to medical imaging, improving diagnostics. The S&P/ASX200 Healthcare Index has underperformed the broader market over five years but remains attractive due to three factors: stable, 'sticky' revenue streams unaffected by economic cycles; strong growth prospects, especially in healthcare IT and SaaS with projected 15%+ annual revenue growth; and rising ethical investing trends favoring essential healthcare services. PME trades at a price-to-sales ratio of 82.77x, slightly above its 5-year average, reflecting valuation considerations amid recent share price changes.